Member of Lyonbiopole
Skyepharma is a French independent CDMO, specialized in the formulation and manufacturing of oral solid dosage forms (small molecules), with a core expertise on complex drugs (modified release, controlled substances, HPAPI, rare diseases).
Skyepharma also offers through its innovative Skyehub concept, tailor-made capacity for clinical and commercial bioproduction.
Strategic application domain: Human Medicine
Application market: Bioproduction, Oncology, Rare disease
Type of activity: CMO - Production - Bioproduction
Technologies: Drug delivery device & Technologies, Small Molecules, Others
Created on oct. 1st, 1996 - 170 employees
Address
55 rue du montmurier 38070 Saint-Quentin-Fallavier
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.
